Role of stiffness and physico-chemical properties of tumour microenvironment on breast cancer cell stemness
Source abstract
Abstract
Several physico-chemical properties of the tumour microenvironment (TME) are dysregulated during tumour progression, such as tissue stiffness, extracellular pH and interstitial fluid flow. Traditional preclinical models, although useful to study biological processes, do not provide sufficient control over these physico-chemical properties, hence limiting the understanding of cause-effect relationships between the TME and cancer cells. Breast cancer stem cells (B-CSCs), a dynamic population within the tumour, are known to affect tumour progression, metastasis and therapeutic resistance. With their emerging importance in disease physiology, it is essential to study the interplay between above-mentioned TME physico-chemical variables and B-CSC marker expression. In this work, 3D in vitro models with controlled physico-chemical properties (hydrogel stiffness and composition, perfusion, pH) were used to mimic normal and tumour breast tissue to study changes in proliferation, morphology and B-CSC population in two separate breast cancer cell lines (MCF-7 and MDA-MB 231). Cells encapsulated in alginate-gelatin hydrogels varying in stiffness (2-10 kPa), density and adhesion ligand (gelatin) were perfused (500 µL/min) for up to 14 days. Physiological (pH 7.4) and tumorigenic (pH 6.5) media were used to mimic changes in extracellular pH within the TME. We found that both cell lines have distinct responses to changes in physico-chemical factors in terms of proliferation, cell aggregates size and morphology. Most importantly, stiff and dense hydrogels (10 kPa) and acidic pH (6.5) play a key role in B-CSCs dynamics, increasing both epithelial (E-CSCs) and mesenchymal cancer stem cell (M-CSCs) marker expression, supporting direct impact of the physico-chemical microenvironment on disease onset and progression. STATEMENT OF SIGNIFICANCE: Currently no studies evaluate the impact of physico-chemical properties of the tumour microenvironment on breast cancer stem cell (B-CSC) marker expression in a single in vitro model and at the same time. In this study, 3D in vitro models with varying stiffness, extracellular pH and fluid flow are used to recapitulate the breast tumour microenvironment to evaluate for the first time their direct effect on multiple breast cancer phenotypes: cell proliferation, cell aggregate size and shape, and B-CSC markers. Results suggest these models could open new ways of monitoring disease phenotypes, from the early-onset to progression, as well as being used as testing platforms for effective identification of specific phenotypes in the presence of relevant tumour physico-chemical microenvironment.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Cancer Cells and Metastasis · 3D Printing in Biomedical Research · Cellular Mechanics and Interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (62)
Show source-provided references
1. Concepts of extracellular matrix remodelling in tumour progression and metastasis10.1038/s41467-020-18794-x ↗
2. Jonietz E. Mechanics: the forces of cancer. Nature2012 4917425. 2012;491(7425):S56-S57. doi:10.1038/491s56a.10.1038/491S56a ↗
3. Beyond tumorigenesis: cancer stem cells in metastasis10.1038/sj.cr.7310118 ↗
4. The role of breast cancer stem cells in metastasis and therapeutic implications10.1016/j.ajpath.2011.03.005 ↗
5. Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells10.1016/j.canlet.2016.07.018 ↗
6. Breast cancer stem cells are involved in Trastuzumab resistance through the HER2 modulation in 3D culture10.1002/jcb.26298 ↗
7. Linking tumor microenvironment to plasticity of cancer stem cells: mechanisms and application in cancer therapy
8. Cancer stem cells and their microenvironment: Biology and therapeutic implications
9. Prospective identification of tumorigenic breast cancer cells10.1073/pnas.0530291100 ↗
10. The biology and role of CD44 in cancer progression: therapeutic implications10.1186/s13045-018-0605-5 ↗
11. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay10.1038/nbt.2576 ↗
12. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?10.1038/nrc3023 ↗
13. CD24: from A to Z10.1038/cmi.2009.119 ↗
14. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome10.1016/j.stem.2007.08.014 ↗
15. Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts10.1016/j.stemcr.2013.11.009 ↗
16. A tense situation: forcing tumour progression10.1038/nrc2544 ↗
17. Biophysics of tumor microenvironment and cancer metastasis - a mini review10.1016/j.csbj.2018.07.003 ↗
18. The extracellular matrix: a dynamic niche in cancer progression10.1083/jcb.201102147 ↗
19. Elastic moduli of normal and pathological human breast tissues: an inversion-technique-based investigation of 169 samples10.1088/0031-9155/52/6/002 ↗
20. Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration10.1039/c5ib00040h ↗
21. Acid-mediated tumor invasion: a multidisciplinary study10.1158/0008-5472.CAN-05-4193 ↗
22. Extracellular pH is a biomarker enabling detection of breast cancer and liver cancer using CEST MRI10.18632/oncotarget.17404 ↗
23. Acidity generated by the tumor microenvironment drives local invasion10.1158/0008-5472.CAN-12-2796 ↗
24. Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells10.1038/sj.onc.1204500 ↗
25. Acid suspends the circadian clock in hypoxia through inhibition of mTOR10.1016/j.cell.2018.05.009 ↗
26. Tumor interstitial fluid formation, characterization, and clinical implications
27. Interstitial fluid flow in cancer: implications for disease progression and treatment10.2147/CMAR.S65444 ↗
28. Interstitial flow and its effects in soft tissues10.1146/annurev.bioeng.9.060906.151850 ↗
29. Polacheck WJ, Charest JL, Kamm RD, Chien S. Interstitial flow influences direction of tumor cell migration through competing mechanisms. doi:10.1073/pnas.1103581108.10.1073/pnas.1103581108 ↗
30. Migration dynamics of breast cancer cells in a tunable 3D interstitial flow chamber10.1039/c1ib00128k ↗
31. Engineering cancer microenvironments for in vitro 3-D tumor models10.1016/j.mattod.2015.05.002 ↗
32. Three-dimensional in vitro cell culture models in drug discovery and drug repositioning10.3389/fphar.2018.00006 ↗
33. Therapeutic implications of cellular heterogeneity and plasticity in breast cancer10.1016/j.stem.2015.08.014 ↗
34. Strain rate viscoelastic analysis of soft and highly hydrated biomaterials10.1002/jbm.a.34914 ↗
35. Functionalized enzyme-responsive biomaterials to model tissue stiffening in vitro10.3389/fbioe.2020.00208 ↗
36. Fabrication of amyloid-β-secreting alginate microbeads for use in modelling Alzheimer's disease10.3791/59597 ↗
37. Cancer cells grown in 3D under fluid flow exhibit an aggressive phenotype and reduced responsiveness to the anti-cancer treatment doxorubicin10.1038/s41598-020-68999-9 ↗
38. A low shear stress modular bioreactor for connected cell culture under high flow rates10.1002/bit.22671 ↗
39. Oxidized alginate beads for tunable release of osteogenically potent mesenchymal stromal cells10.1016/j.msec.2019.109911 ↗
40. Oxidized alginate-gelatin hydrogel: a favorable matrix for growth and osteogenic differentiation of adipose-derived stem cells in 3D10.1021/acsbiomaterials.7b00188 ↗
41. 3D inkjet printing of complex, cell-laden hydrogel structures10.1038/s41598-018-35504-2 ↗
42. Zhang B, Shan DH, Li D, Li Z ran, Zhu K shun, Jiang Z. bo, Huang M sheng. Different methods of detaching adherent cells significantly affect the detection of TRAIL receptors. doi:10.1177/030089161209800619.10.1177/030089161209800619 ↗
43. Colorectal tumor 3D in vitro models: advantages of biofabrication for the recapitulation of early stages of tumour development
44. Microenvironment complexity and matrix stiffness regulate breast cancer cell activity in a 3D in vitro model10.1038/srep35367 ↗
45. Identification of an easy to use 3D culture model to investigate invasion and anticancer drug response in chondrosarcomas10.1186/s12885-017-3478-z ↗
46. Tunable synthetic extracellular matrices to investigate breast cancer response to biophysical and biochemical cues10.1063/1.5064596 ↗
47. Reconstituting organ-level lung functions on a chip10.1126/science.1188302 ↗
48. Disease modeling using 3D organoids derived from human induced pluripotent stem cells10.3390/ijms19040936 ↗
49. A cell-ECM screening method to predict breast cancer metastasis †10.1039/C4IB00218K ↗
50. In vitro models of cancer stem cells and clinical applications
51. Alginate: properties and biomedical applications10.1016/j.progpolymsci.2011.06.003 ↗
52. A tough act to follow: collagen hydrogel modifications to improve mechanical and growth factor loading capabilities
53. Synthetic alternatives to Matrigel10.1038/s41578-020-0199-8 ↗
54. A practical guide to hydrogels for cell culture10.1038/nmeth.3839 ↗
55. Frequency-dependent interactions determine outcome of competition between two breast cancer cell lines10.1038/s41598-021-84406-3 ↗
56. Bioengineered 3D platform to explore cell–ECM interactions and drug resistance of epithelial ovarian cancer cells10.1016/j.biomaterials.2010.07.064 ↗
57. The independent roles of mechanical, structural and adhesion characteristics of 3D hydrogels on the regulation of cancer invasion and dissemination10.1016/j.biomaterials.2013.08.077 ↗
58. β1 integrin regulates Arg to promote invadopodial maturation and matrix degradation10.1091/mbc.e12-12-0908 ↗
59. Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer10.1186/s12943-018-0809-x ↗
60. Targeting biophysical cues: a niche approach to study, diagnose, and treat cancer10.1016/j.trecan.2018.02.006 ↗
61. Manipulating tumor acidification as a cancer treatment strategy
62. Bicarbonate increases tumor pH and inhibits spontaneous metastases10.1158/0008-5472.CAN-07-5575 ↗